Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Mycol Med ; 29(3): 253-259, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31399349

RESUMEN

The search for new antifungal strategies to overcome Candida infections is essential and a matter of public health, due to the high mortality associated to candidiasis, the increasing incidence of resistance to antifungals and the limited number of drugs available for treatment. Several approaches have been exploited in order to develop new antifungal strategies, e.g. the use of natural products, vaccines, and the combination of an antifungal drug to a non-antifungal substance. Nonetheless, issues related to pharmacokinetic parameters, toxicity and costs have been jeopardizing the discovery of new antifungal drugs. An alternative that could overcome these problems would be treating candidiasis with drugs that have been originally developed to treat other diseases. This strategy, known as drug repositioning or drug repurposing, could diminish the incidence of adverse effects and lower the cost of production, since several steps involved in drug discovery and development have already been accomplished. This review presents a set of known drugs that have been exploited as anticandidal agents, such as antidepressant agents, antiepileptic drugs, statins, among others. These substances affect the growth of Candida spp. in vitro, as well as virulence factors such as morphogenesis and biofilm formation. Moreover, some drugs are able to potentiate the anticandidal activity of known antifungal drugs. Drug repositioning appears as a remarkable alternative to increase the pharmacological arsenal against candidiasis, but further studies must be conducted in order to evaluate the real applicability of known drugs in the treatment of these infections.


Asunto(s)
Antifúngicos/farmacología , Candida/efectos de los fármacos , Descubrimiento de Drogas , Reposicionamiento de Medicamentos , Animales , Antidepresivos/uso terapéutico , Antifúngicos/efectos adversos , Biopelículas/efectos de los fármacos , Candida/crecimiento & desarrollo , Candida albicans/efectos de los fármacos , Candidiasis/tratamiento farmacológico , Farmacorresistencia Fúngica Múltiple , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Ratones , Pruebas de Sensibilidad Microbiana
2.
J Mycol Med ; 28(1): 137-142, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29217144

RESUMEN

BACKGROUND: Candidiasis is a major opportunistic fungal infection in humans. The low number of antifungal drugs available to treat Candida infections and the increasing incidence of multidrug resistant (MDR) strains point to an urgent need of identifying new therapeutic options. The role of salivary components can provide insights for the development of new methodologies of control. OBJECTIVE: The aim of this study was to evaluate the ability of histatin-5, a constitutive immunological peptide present in saliva, in reversing fungal MDR phenotype, using a resistant Saccharomyces cerevisiae strain as model of study. RESULTS: A total of 2.5µg and 5µg of histatin-5 revealed to be able to chemosensitize (to revert antifungal resistance) a MDR strain to fluconazole impairing its intrinsic resistance. The presence of histatin-5 decreased the strain growth when associated to fluconazole, and also assisted in the retention of rhodamine 6G within cell cytoplasm. The ATPase activity of Pdr5p, an ABC efflux transporter, was significantly reduced up to 65% within physiological concentration of the peptide. CONCLUSION: Results revealed that histatin-5 is able to revert MDR phenotype and may be considered a potential alternative MDR inhibitor. Since Pdr5p is homologous to Candida albicans CaCdr1p and CaCdr2p, data obtained might be extrapolated to these transporters, inferring that associating fluconazole and histatin-5 may be a useful tool to circumvent failure treatments of infections caused by Candida MDR strains.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/efectos de los fármacos , Antifúngicos/farmacología , Farmacorresistencia Fúngica Múltiple/efectos de los fármacos , Fluconazol/farmacología , Histatinas/farmacología , Proteínas de Saccharomyces cerevisiae/efectos de los fármacos , Saccharomyces cerevisiae/efectos de los fármacos , Transportadoras de Casetes de Unión a ATP/genética , Transporte Biológico , Candidiasis/tratamiento farmacológico , Farmacorresistencia Fúngica Múltiple/genética , Histatinas/química , Histatinas/aislamiento & purificación , Humanos , Pruebas de Sensibilidad Microbiana , Rodaminas/análisis , Rodaminas/metabolismo , Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/genética , Saliva/química
3.
Artículo en Inglés | MEDLINE | ID: mdl-27821447

RESUMEN

Invasive Candida albicans infections are a serious health threat for immunocompromised individuals. Fluconazole is most commonly used to treat these infections, but resistance due to the overexpression of multidrug efflux pumps is of grave concern. This study evaluated the ability of five synthetic organotellurium compounds to reverse the fluconazole resistance of C. albicans clinical isolates. Compounds 1 to 4, at <10 µg/ml, ameliorated the fluconazole resistance of Saccharomyces cerevisiae strains overexpressing the major C. albicans multidrug efflux pumps Cdr1p and Mdr1p, whereas compound 5 only sensitized Mdr1p-overexpressing strains to fluconazole. Compounds 1 to 4 also inhibited efflux of the fluorescent substrate rhodamine 6G and the ATPase activity of Cdr1p, whereas all five of compounds 1 to 5 inhibited Nile red efflux by Mdr1p. Interestingly, all five compounds demonstrated synergy with fluconazole against efflux pump-overexpressing fluconazole-resistant C. albicans clinical isolates, isolate 95-142 overexpressing CDR1 and CDR2, isolate 96-25 overexpressing MDR1 and ERG11, and isolate 12-99 overexpressing CDR1, CDR2, MDR1, and ERG11 Overall, organotellurium compounds 1 and 2 were the most promising fluconazole chemosensitizers of fluconazole-resistant C. albicans isolates. Our data suggest that these novel organotellurium compounds inhibit pump efflux by two very important and distinct families of fungal multidrug efflux pumps: the ATP-binding cassette transporter Cdr1p and the major facilitator superfamily transporter Mdr1p.


Asunto(s)
Antifúngicos/farmacología , Candida albicans/efectos de los fármacos , Fluconazol/farmacología , Candida albicans/genética , Candida albicans/metabolismo , Farmacorresistencia Fúngica/genética , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Regulación Fúngica de la Expresión Génica/efectos de los fármacos , Regulación Fúngica de la Expresión Génica/genética , Pruebas de Sensibilidad Microbiana , Compuestos de Organotecnecio/farmacología , Saccharomyces cerevisiae/efectos de los fármacos , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo
4.
Insect Mol Biol ; 22(6): 648-58, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23980723

RESUMEN

Re-emergence of vector-borne diseases such as dengue and yellow fever, which are both transmitted by the Aedes aegypti mosquito, has been correlated with insecticide resistance. P-glycoproteins (P-gps) are ATP-dependent efflux pumps that are involved in the transport of substrates across membranes. Some of these proteins have been implicated in multidrug resistance (MDR). In this study, we identified a putative P-glycoprotein in the Ae. aegypti database based on its significantly high identity with Anopheles gambiae, Culex quinquefasciatus, Drosophila melanogaster and human P-gps. The basal ATPase activity of ATP-binding cassette transporters in larvae was significantly increased in the presence of MDR modulators (verapamil and quinidine). An eightfold increase in Ae. aegypti P-gp (AaegP-gp) gene expression was detected in temephos-treated larvae as determined by quantitative PCR. To analyse the potential role of AaegP-gp in insecticide efflux, a temephos larvicide assay was performed in the presence of verapamil. The results showed an increase of 24% in temephos toxicity, which is in agreement with the efflux reversing effect. RNA interference (RNAi)-mediated silencing of the AaegP-gp gene caused a significant increase in temephos toxicity (57%). In conclusion, we have demonstrated for the first time in insects that insecticide-induced P-gp expression can be involved in the modulation of insecticide efflux.


Asunto(s)
Aedes/efectos de los fármacos , Larva/efectos de los fármacos , Temefós , Subfamilia B de Transportador de Casetes de Unión a ATP , Transportadoras de Casetes de Unión a ATP/metabolismo , Secuencia de Aminoácidos , Animales , Expresión Génica/efectos de los fármacos , Resistencia a los Insecticidas/genética , Datos de Secuencia Molecular , Mortalidad , Quinidina/farmacología , Verapamilo/farmacología
5.
Med Mycol ; 50(1): 26-32, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21539505

RESUMEN

The primary objective of this work was to evaluate the capability of curcumin, a natural compound found in the Curcuma longa plant, to sensitize a clinical isolate of Candida albicans, which was found to have a high resistance to fluconazole. In addition, we assessed whether the resistance of this isolate was the result of the existence of efflux pumps, which could confer a multiple drug resistance phenotype. To evaluate azole resistance, we used the Clinical Laboratory Standard Institute (CLSI) MIC assays procedures with minor modifications. For evaluation of synergistic interaction of curcumin and fluconazole, checkerboard experiments were employed. Nile red and Rhodamine 6G accumulation assays were used to evaluate efflux pump activity. Curcumin was found to have a great capability to inhibit fluconazole resistance of the isolate of C. albicans. It was capable of restoring its sensitivity to this azole when used at 11 µM. Analysis with different azoles and the two indicated dyes showed that an efflux pump could be acting and contributing to the resistance of this isolate to fluconazole. The results suggest that a major facilitator superfamily (MFS) transporter might be involved in this process.


Asunto(s)
Antifúngicos/farmacología , Candida albicans/efectos de los fármacos , Curcumina/farmacología , Farmacorresistencia Fúngica Múltiple/efectos de los fármacos , Fluconazol/farmacología , Transporte Biológico Activo/efectos de los fármacos , Curcuma/química , Humanos , Pruebas de Sensibilidad Microbiana , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología
6.
Phytochem Anal ; 21(6): 539-43, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21043038

RESUMEN

INTRODUCTION: Phytochemical and biological studies carried out on Copaifera species showed that their oleoresins and isolated compounds have various biological activities. OBJECTIVE: The aims of this work were (i) to analyse the Copaifera oleoresin by gas chromatography-mass spectrometry, (ii) to isolate the diterpenic acids from this oleoresin by high-speed countercurrent chromatography (HSCCC) and (iii) to determine the rhodamine 6G Pdr5p activity of these acids. METHODOLOGY: HSCCC was used for the preparative separation of the diterpenes. Spectroscopic methods were used to establish their identity. RESULTS: The gas chromatogram of the oleoresin showed approximately 30 compounds. The two major ones, kaur-16-en-18-oic and polyalthic acids, were isolated in high purity. Kaur-16-en-18-oic acid exhibited the highest rodomine 6G Pdr5p activity among the tested compounds. CONCLUSION: HSCCC was shown to be a quick and effective tool in the isolation and purification of diterpenes from Copaifera oleoresin. This is the first report on the use of HSCCC for the fractionation of an oleoresin from Copaifera and the isolation of diterpenes therein.


Asunto(s)
Diterpenos/aislamiento & purificación , Fabaceae/química , Resinas de Plantas/química , Transportadoras de Casetes de Unión a ATP/antagonistas & inhibidores , Transportadoras de Casetes de Unión a ATP/metabolismo , Brasil , Contrainmunoelectroforesis , Diterpenos/química , Diterpenos/farmacología , Colorantes Fluorescentes , Cromatografía de Gases y Espectrometría de Masas , Espectroscopía de Resonancia Magnética , Aceites de Plantas/análisis , Rodaminas , Saccharomyces cerevisiae/efectos de los fármacos , Saccharomyces cerevisiae/metabolismo , Proteínas de Saccharomyces cerevisiae/antagonistas & inhibidores , Proteínas de Saccharomyces cerevisiae/metabolismo , Solventes
7.
Curr Microbiol ; 47(4): 265-71, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-14629005

RESUMEN

In the present work we characterized the ecto-ATP diphosphohydrolase activity of the trypanosomatid parasite Herpetomonas muscarum muscarum. This parasite hydrolyzed ATP at a rate of 15.52 nmol Pi/mg protein/min and this activity reached a maximum at pH 7.5. Classical inhibitors of acid phosphatases, such as sodium orthovanadate (NaVO3), sodium fluoride (NaF), and ammonium molybdate presented no effect on this activity. MgCl2, ZnCl2, and MnCl2 stimulated the ATP hydrolysis by H. m. muscarum. The ecto-ATPase activity was insensitive to oligomycin and sodium azide, two inhibitors of mitochondrial Mg-ATPase, bafilomycin A1, a V-ATPase inhibitor, ouabain, a Na(+)+K+-ATPase inhibitor and to levamizole, an inhibitor of alkaline phosphatase. An extracellular impermeant inhibitor 4,4'-diisothiocyanostylbene 2',2'-disulfonic acid (DIDS) and a inhibitor of some ecto-ATPases, suramin, which is also a competitive antagonist of P2-purinergic receptors, promoted a great inhibition on the ATP hydrolysis. This enzyme is able to hydrolysis ATP, ADP, UTP, and UDP, but not GTP, GDP, CTP, or CDP. ADP inhibited the enzymatic activity in a concentration dependent manner, reaching 70% inhibition.


Asunto(s)
Apirasa/aislamiento & purificación , Apirasa/metabolismo , Trypanosomatina/enzimología , Ácido 4,4'-Diisotiocianostilbeno-2,2'-Disulfónico/farmacología , Animales , Antígenos CD , Cationes Bivalentes/farmacología , Activadores de Enzimas/análisis , Activadores de Enzimas/farmacología , Inhibidores Enzimáticos/farmacología , Estabilidad de Enzimas/efectos de los fármacos , Concentración de Iones de Hidrógeno , Magnesio/farmacología , Especificidad por Sustrato , Suramina/farmacología , Tripanocidas/farmacología
8.
Eur J Biochem ; 266(2): 660-4, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10561610

RESUMEN

Yeast cells have had to develop mechanisms in order to protect themselves from chemical and physical agents of the environment to which they are exposed. One of these physical agents is thermal variation. Some yeast cells are known to accumulate high concentrations of trehalose when submitted to heat shock. In this work, we have studied the effect of trehalose on the protection against thermal inactivation of purified plasma membrane H+-ATPase from Schizosaccharomyces pombe, in the solubilized and in the reconstituted state. We observed that after 1 min of incubation at 51 degrees C in the presence of 1 M trehalose, about 50% of soluble enzyme remains active. In the same conditions, but in the absence of trehalose, the activity was completely abolished. The t0.5 for the enzyme inactivation increased from 10 to 50 s after reconstitution into asolectin liposomes. Curiously, in the presence of 1 M trehalose, the t0.5 for inactivation of the reconstituted enzyme was further increased to higher than 300 s, regardless of whether trehalose was added inside or outside the liposome. Additionally, the concentration that confers 50% for the protection by trehalose (K0.5) decreased from 0.5 M, in the solubilized state, to 0.04 M in the reconstituted state, suggesting a synergetic effect between sugar and lipids. Gel electrophoresis revealed that the pattern of H+-ATPase cleavage by trypsin changed when 1 M trehalose was present in the buffer. It is suggested that both in a soluble and in a phospholipid environment, accumulation of trehalose leads to a more heat-stable conformation of the enzyme, probably an E2-like form.


Asunto(s)
Membrana Celular/enzimología , ATPasas de Translocación de Protón/química , Trehalosa/química , Adenosina Trifosfatasas/metabolismo , Carbohidratos/química , Relación Dosis-Respuesta a Droga , Electroforesis en Gel de Poliacrilamida , Cinética , Fosfatidilcolinas , Fosfolípidos/química , Fosfolípidos/metabolismo , Conformación Proteica , Desnaturalización Proteica , ATPasas de Translocación de Protón/metabolismo , Schizosaccharomyces/enzimología , Temperatura , Factores de Tiempo , Trehalosa/farmacología , Levaduras/enzimología
9.
Comp Biochem Physiol B Biochem Mol Biol ; 122(3): 269-76, 1999 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10374256

RESUMEN

In the present report we describe a method for purifying plasma membranes from chicken erythrocytes using sonication under conditions that facilitate preferential lysis of plasma membrane, followed by centrifugation through a sucrose gradient. The Ca(2+)-dependent ATP hydrolysis by plasma membranes is activated by nanomolar levels of calmodulin, similarly to that from anucleated erythrocytes. Inside-out vesicles display a calmodulin-activated Ca2+ uptake. Purified Ca(2+)-ATPase is obtained from the plasma membrane by Sepharose-calmodulin affinity chromatography, and exhibits an apparent molecular mass of 150 kDa on SDS-polyacrylamide gel electrophoresis, clearly showing that the enzyme is distinct from that described in anucleated erythrocytes (140 kDa). The enzyme is insensitive to physiological concentrations of taurine, a beta-amino acid that has been proposed to be involved in Ca2+ homeostasis of nucleated erythrocytes, suggesting that the effect of taurine is not mediated by the Ca(2+)-ATPase. Taken together, these data suggest that the enzyme may be an isoform that resembles the previously described plasma membrane Ca(2+)-ATPase from anucleated erythrocytes in its regulation by calmodulin, but differs in its apparent molecular weight.


Asunto(s)
ATPasas Transportadoras de Calcio/efectos de los fármacos , Calcio/metabolismo , Calmodulina/farmacología , Membrana Eritrocítica/metabolismo , Taurina/farmacología , Adenosina Trifosfato/metabolismo , Alameticina/farmacología , Animales , ATPasas Transportadoras de Calcio/antagonistas & inhibidores , ATPasas Transportadoras de Calcio/metabolismo , Calmodulina/metabolismo , Pollos , Cromatografía Liquida , Electroforesis en Gel de Poliacrilamida/métodos , Inhibidores Enzimáticos/farmacología , Membrana Eritrocítica/efectos de los fármacos , Femenino , Masculino , Solubilidad , Taurina/metabolismo , Tapsigargina/farmacología
10.
Eur J Biochem ; 248(1): 24-9, 1997 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-9310355

RESUMEN

Baker's yeast cells accumulate osmolytes as a response to several stress conditions such as high-temperature and low-temperature shifts, dehydration, or osmotic stress. One of the major osmolytes that accumulates is trehalose, which plays an essential role affecting the survival of yeast at the time of stress. In this report, we show that trehalose efficiently protects the function and the structure of two yeast cytosolic enzymes against chemical denaturation by guanidinium chloride. Other sugars tested also protected yeast pyrophosphatase and glucose-6-phosphate dehydrogenase structure against guanidinium chloride effects, but were not as efficient at protecting enzyme activity. The thermostable pyrophosphatase from Bacillus stearothermophilus was also protected by several sugars against the chaotropic properties of guanidinium chloride, but was only protected by trehalose against functional inactivation. The function of the membrane-embedded H+-ATPase from yeast could not be protected by any of the tested sugars, although all of the sugars protected its structure from guanidinium-chloride-induced unfolding. The results presented in this study suggest that several sugars are able to prevent protein unfolding induced by a chaotropic compound. However, prevention of functional inactivation depends on the nature of the sugar. Trehalose was the most efficient, being able to protect many cytosolic enzymes against guanidinium chloride. The efficiency of protection also depended on the nature of the protein tested. This might explain why trehalose is one of the osmolytes accumulated in yeast and also why it is not the only osmolyte to accumulate.


Asunto(s)
Carbohidratos/farmacología , Enzimas/química , Enzimas/metabolismo , Inhibidores Enzimáticos/farmacología , Estabilidad de Enzimas/efectos de los fármacos , Enzimas/efectos de los fármacos , Geobacillus stearothermophilus/enzimología , Glucosafosfato Deshidrogenasa/química , Glucosafosfato Deshidrogenasa/efectos de los fármacos , Glucosafosfato Deshidrogenasa/metabolismo , Guanidina , Guanidinas/farmacología , Pirofosfatasa Inorgánica , Cinética , Desnaturalización Proteica/efectos de los fármacos , Pliegue de Proteína , Estructura Terciaria de Proteína/efectos de los fármacos , ATPasas de Translocación de Protón/química , ATPasas de Translocación de Protón/efectos de los fármacos , ATPasas de Translocación de Protón/metabolismo , Pirofosfatasas/química , Pirofosfatasas/efectos de los fármacos , Pirofosfatasas/metabolismo , Saccharomyces cerevisiae/enzimología , Trehalosa/farmacología
11.
J Biol Chem ; 269(16): 12074-9, 1994 Apr 22.
Artículo en Inglés | MEDLINE | ID: mdl-8163511

RESUMEN

The H(+)-ATPase from Schizosaccharomyces pombe belongs to the group of transport ATPases which displays two main conformational states, E1 and E2 (P-type ATPase). In this report, we show that, as in the case of other P-type ATPase, the purified enzyme exhibits a p-nitrophenylphosphatase activity which can be completely inhibited by vanadate. In aqueous medium, p-nitrophenyl phosphate hydrolysis proceeds at only 0.5% of the rate of ATP hydrolysis, and both activities can be stimulated 3- to 4-fold by decreasing the pH from 7.5 to 6.5. Addition of the organic solvent dimethyl sulfoxide (10-40%), which has been shown to favor the E2 conformation, stimulates the p-nitrophenylphosphatase activity but inhibits the ATPase activity. At pH 7.5, the Km for p-nitrophenyl phosphate decreases when dimethyl sulfoxide is present. In the presence of 30% (v/v) dimethyl sulfoxide, the phosphatase activity can be inhibited by ATP (K(i) 300 microM) or by P(i) (K(i) 1 mM). The H(+)-ATPase incorporated into liposomes retains pNPPase activity, but it does not support H+ transport. Gel electrophoresis reveals that the pattern of H(+)-ATPase cleavage by trypsin changes when vanadate, Me2SO, or both compounds are present in the medium, regardless of the pH used during trypsinization. We propose that p-nitrophenyl phosphate is hydrolyzed by a H(+)-ATPase conformation distinct from that which hydrolyzes ATP, most probably an E2-like form. We also suggest that, in addition to the E1-E2 transition, the enzyme activity can be regulated by protons at another step of the catalytic cycle.


Asunto(s)
4-Nitrofenilfosfatasa/metabolismo , Membrana Celular/enzimología , ATPasas de Translocación de Protón/metabolismo , Schizosaccharomyces/enzimología , 4-Nitrofenilfosfatasa/antagonistas & inhibidores , 4-Nitrofenilfosfatasa/aislamiento & purificación , Dimetilsulfóxido/farmacología , Electroforesis en Gel de Poliacrilamida , Activación Enzimática , Cinética , Liposomas , Peso Molecular , Fragmentos de Péptidos/aislamiento & purificación , Fosfatos/farmacología , ATPasas de Translocación de Protón/aislamiento & purificación , Tripsina , Vanadatos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...